Michael E Johnson Selected Research

Michael E Johnson Research Topics

Disease

8	Neoplasms (Cancer) 01/2020 - 09/2006
5	Infections 01/2018 - 05/2009
5	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 09/2006
2	Severe Acute Respiratory Syndrome 10/2008 - 11/2005
2	Dry Eye Syndromes (Dry Eye Syndrome) 10/2007 - 01/2006
2	Acidosis 06/2007 - 07/2004
2	Necrosis 11/2004 - 12/2002
1	Heart Failure 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Chronic Periodontitis 01/2018
1	Systemic Scleroderma (Systemic Sclerosis) 01/2016
1	Tularemia 03/2015
1	Pain (Aches) 03/2013
1	Wound Infection (Wound Infections) 03/2013
1	Wounds and Injuries (Trauma) 03/2013
1	Tuberculosis (Tuberculoses) 05/2009
1	Renal Insufficiency (Renal Failure) 04/2008
1	Adenocarcinoma 06/2007
1	Surgical Wound 06/2007
1	Propofol Infusion Syndrome 06/2007
1	Atrial Flutter (Flutter, Atrial) 06/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2004
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2003
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 07/2002

Drug/Important Bio-Agent (IBA)

3	Cardiac GlycosidesIBA 01/2020 - 01/2017
2	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2007
2	Biological ProductsIBA 03/2015 - 11/2005
2	Local AnestheticsIBA 03/2013 - 12/2002
2	Pharmaceutical PreparationsIBA 05/2009 - 03/2003
2	OligonucleotidesIBA 06/2007 - 09/2006
2	Propofol (Diprivan)FDA LinkGeneric 06/2007 - 07/2004
1	CardenolidesIBA 01/2020
1	Digoxin (Digitek)FDA LinkGeneric 01/2020
1	LactonesIBA 01/2020
1	EnzymesIBA 01/2018
1	ApigeninIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	FlavonoidsIBA 01/2018
1	strebloside-IBA 01/2017
1	AutoantibodiesIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2015
1	Ropivacaine (Naropin)FDA LinkGeneric 03/2013
1	Narcotics (Narcotic Analgesics)IBA 03/2013
1	Caspofungin (Cancidas)FDA Link 12/2012
1	Anidulafungin FDA Link 12/2012
1	Micafungin (FK463)FDA Link 12/2012
1	EchinocandinsIBA 12/2012
1	AzolesIBA 12/2012
1	HCV NS3-4A Protease InhibitorsIBA 08/2012
1	microfibrillar proteinIBA 12/2009
1	Integrin beta3 (GPIIIa)IBA 12/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2009
1	HLA-DM antigens (HLA-DMA)IBA 12/2008
1	PapainIBA 10/2008
1	Peptide Hydrolases (Proteases)FDA Link 10/2008
1	Tranexamic Acid (AMCA)FDA Link 04/2008
1	LubricantsIBA 10/2007
1	Fibroblast Growth Factor 1 (FGF-1)IBA 06/2007
1	Anesthetics (Anesthetic Agents)IBA 06/2007
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2006
1	Ophthalmic Solutions (Eye Drops)IBA 01/2006
1	Hyaluronic Acid (Hyaluronan)IBA 01/2006
1	Lubricant Eye Drops (Artificial Tears)IBA 01/2006
1	Chymases (Chymase)IBA 11/2005
1	PeptidomimeticsIBA 11/2005
1	Lidocaine (Xylocaine)FDA LinkGeneric 11/2004
1	sickle deoxyhemoglobinIBA 03/2003
1	Oxygen (Dioxygen)IBA 03/2003
1	IsothiocyanatesIBA 03/2003
1	Hemoglobins (Hemoglobin)IBA 03/2003
1	Sickle HemoglobinIBA 03/2003
1	CalciumIBA 12/2002
1	SpectrinIBA 07/2002

Therapy/Procedure

1	Length of Stay 03/2013
1	Therapeutics 08/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2008
1	Aftercare (After-Treatment) 10/2007
1	Radiofrequency Ablation 06/2007
1	Carotid Endarterectomy 06/2007
1	Catheters 06/2007